Results

1–10 of 12 results for vision loss

Multiwavelength Photobiomodulation Significantly Reduces Risk for Vision Loss and Onset of Geographic Atrophy in Dry Age-Related Macular Degeneration
Eleonora Lad, MD, PhD
Updates from the Field
2024
Acute Vision Loss in a 66-Year-Old White Female: A Diagnostic and Therapeutic Challenge
On Demand Cases, Courses, and Papers
2022
Effects of the Mitochondria-Targeted Drug Elamipretide on Leakage-Independent Vision Loss in Fellow Eyes with Neovascular AMD in the ReCLAIM Study
Priyatham (Prithu) S Mettu, MD
Updates from the Field
2019
Elamipretide, a Mitochondrial-Targeted Drug, for the Treatment of Vision Loss in Dry AMD with High Risk Drusen
Michael J Allingham, MD, PhD
Annual Meeting Talks
2019
Mitochondria-Targeted Drug Elamipretide for Treatment of Vision Loss in Dry AMD With Noncentral Geographic Atrophy
Scott W. Cousins, MD
Annual Meeting Talks
2019
Vision Loss in a Patient With Primary Pulmonary Hypertension and Long-Term Use of Sildenafil
Christina Y Weng, MD, MBA, FASRS
Annual Meeting Talks
2016
“Real World” U.S. Outcomes of Anti-VEGF Therapy in Neovascular AMD: Risk of Vision Loss is Greatest in Patients with Better Baseline Visual Acuity
Thomas A. Ciulla, MD, MBA, FASRS
Annual Meeting Talks
2016
Episode 162: April 2019 Retinal Physician Preview Discussion of AMD Topics with Dr. Margaret Greven and Dr. M. Ali Khan
Jayanth Sridhar, MD
Member Podcasts
2018
Severe Vision Loss After Intravitreal Injections of Autologous Adipose Tissue-derived Stem Cells for Age-Related Macular
Ajay E Kuriyan, MD, MS
Updates from the Field
2016
Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss
Jennifer K. Sun, MD
Updates from the Field
2019